Zepp Health Corporation (ZEPP) — Financial statements
Income statement, balance sheet, and cash flow for Zepp Health Corporation — annual and quarterly history with growth and margin analysis.
| Metric (CNY Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,815↑36.1% | 1,333↓46.6% | 2,498↓40.8% | 4,216↓31.7% | 6,169 | |
| Cost of Revenue | 1,104↑34.5% | 821↓55.5% | 1,844↓45.7% | 3,398↓30.4% | 4,880 | |
| Gross Profit | 712↑38.8% | 513↓21.5% | 654↓20.0% | 817↓36.6% | 1,289 | |
| Operating Expenses | ||||||
| R&D Expenses | 318↓5.7% | 337↓7.5% | 365↓30.7% | 526↑3.5% | 508 | |
| General & Administrative Expenses | 0.00↓100.0% | 181 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 339 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 583↑11.9% | 521↑3.2% | 505↓28.8% | 708↑3.0% | 688 | |
| Other Expenses | 16 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 917↑6.8% | 858↓1.3% | 869↓29.6% | 1,235↑3.2% | 1,196 | |
| Total Costs & Expenses | 2,020↑20.4% | 1,678↓38.1% | 2,713↓41.4% | 4,633↓23.8% | 6,076 | |
| Operating Results | ||||||
| Operating Income | -205↑40.6% | -345↓60.1% | -216↑48.4% | -417↓550.2% | 93 | |
| Depreciation & Amortization | 0.00↓100.0% | 37↓32.7% | 54↓8.7% | 60↑16.5% | 51 | |
| EBITDA | -205↑40.7% | -346↓141.9% | -143↑45.3% | -261↓230.2% | 201 | |
| EBIT | -205↑46.4% | -382↓93.8% | -197↑38.5% | -321↓314.6% | 150 | |
| Interest & Other Income | ||||||
| Net Interest Income | -29↓113.0% | -14↑47.0% | -26↑43.0% | -45↓63.3% | -28 | |
| Interest Income | 11↓60.1% | 27↑22.6% | 22↑74.2% | 13↓23.8% | 16 | |
| Interest Expense | 40↓1.5% | 41↓15.2% | 48↓17.6% | 58↑30.9% | 44 | |
| Non-Operating Income | 0.00↓100.0% | 37↑304.6% | -18↑81.1% | -96↓69.5% | -57 | |
| Other Income / Expenses | -58↑46.4% | -109↓400.2% | -22↓138.5% | 56↑6.2% | 53 | |
| Income Before Tax | -263↑42.0% | -454↓91.2% | -237↑34.3% | -361↓347.7% | 146 | |
| Income Tax Expense | 18↓82.2% | 100↑681.4% | -17↑74.3% | -67↓732.0% | 11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -281↑49.3% | -554↓151.6% | -220↑25.2% | -294↓317.5% | 135 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -281↑49.3% | -554↓151.3% | -220↑24.8% | -293↓315.7% | 136 | |
| Bottom-Line Net Income | -281↑49.2% | -553↓151.9% | -220↑25.2% | -293↓315.7% | 136 | |
| EPS (Basic) | -283.04↓728.6% | -34.16↓1642.9% | -1.96↑27.7% | -2.71↓296.4% | 1.38 | |
| EPS (Diluted) | -283.04↓728.6% | -34.16↓1642.9% | -1.96↑27.7% | -2.71↓306.9% | 1.31 | |
| Weighted Average Shares | 0.99↓93.9% | 16↑6.5% | 15↓1.3% | 15↓2.3% | 16 | |
| Weighted Average Diluted Shares | 0.99↓93.9% | 16↑6.5% | 15↓1.3% | 15↓6.8% | 17 | |
* All figures in Millions of CNY, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.